Ubiquitin Ligase TRIM15 Promotes the Progression of Pancreatic Cancer Via the Upregulation of the IGF2BP2-TLR4 Axis
Hongkun Cai,Jingyuan Zhao,Qiyue Zhang,Heyu Wu,Yan Sun,Feng Guo,Yingke Zhou,Gengdu Qin,Wentao Xia,Yuhan Zhao,Xueyi Liang,Shilin Yin,Yang Qin,Dan Li,Heshui Wu,Dianyun Ren
DOI: https://doi.org/10.1016/j.bbadis.2024.167183
2024-01-01
Biochimica et Biophysica Acta - Molecular Basis of Disease
Abstract:BackgroundThe tripartite motif family, predominantly characterized by its E3 ubiquitin ligase activities, is involved in various cellular processes including signal transduction, apoptosis and autophagy, protein quality control, immune regulation, and carcinogenesis. Tripartite Motif Containing 15 (TRIM15) plays an important role in melanoma progression through extracellular signal-regulated kinase activation; however, data on its role in pancreatic tumors remain lacking. We previously demonstrated that TRIM15 targeted lipid synthesis and metabolism in pancreatic cancer; however, other specific regulatory mechanisms remain elusive.MethodsWe used transcriptomics and proteomics, conducted a series of phenotypic experiments, and used a mouse orthotopic transplantation model to study the specific mechanism of TRIM15 in pancreatic cancer in vitro and in vivo.ResultsTRIM15 overexpression promoted the progression of pancreatic cancer by upregulating the toll-like receptor 4. The TRIM15 binding protein, IGF2BP2, could combine with TLR4 to inhibit its mRNA degradation. Furthermore, the ubiquitin level of IGF2BP2 was positively correlated with TRIM15.ConclusionsTRIM15 could ubiquitinate IGF2BP2 to enhance the function of phase separation and the maintenance of mRNA stability of TLR4. TRIM15 is a potential therapeutic target against pancreatic cancer.